C57BL/6JCya-Ccn6em1/Cya
Common Name
Ccn6-KO
Product ID
S-KO-09382
Backgroud
C57BL/6JCya
Strain ID
KOCMP-327743-Ccn6-B6J-VA
When using this mouse strain in a publication, please cite “Ccn6-KO Mouse (Catalog S-KO-09382) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Ccn6-KO
Strain ID
KOCMP-327743-Ccn6-B6J-VA
Gene Name
Product ID
S-KO-09382
Gene Alias
Gm735, WISP-3, Wisp3
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 10
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000076713
NCBI RefSeq
NM_001127376
Target Region
Exon 2~3
Size of Effective Region
~3.6 kb
Overview of Gene Research
Ccn6, also known as WISP3, is a gene encoding a matrix-associated protein of the CCN family. It has regulatory roles in development and cancer, with a conserved multimodular structure similar to other CCN proteins. Ccn6 is involved in pathways such as epithelial-to-mesenchymal transitions (EMT) and Notch signaling, and is of great biological importance in processes like maintaining cell phenotypes and in mitochondrial function [1,2]. Genetic models, especially knockout mouse models, are valuable for studying its functions.
In breast cancer, Ccn6 is a tumor suppressor. Conditional, mammary epithelial-cell specific ccn6 (wisp3) knockout mice develop invasive high-grade mammary carcinomas that recapitulate human spindle cell metaplastic carcinomas. This indicates that Ccn6 loss is associated with aggressive breast cancers, such as metaplastic carcinomas where its expression is reduced. Ccn6 suppresses metaplastic breast carcinoma by antagonizing Wnt/β-Catenin signaling to inhibit EZH2-driven EMT. In these carcinomas, Ccn6 interacts with Wnt receptors to block β-catenin/TCF-mediated transcription, and EZH2, a target of this signaling, can be a therapeutic target when Ccn6 is deficient [1,3].
In summary, Ccn6 is crucial for maintaining normal biological functions, especially in breast tissue where it acts as a tumor suppressor. The use of ccn6 knockout mouse models has been instrumental in revealing its role in breast cancer, particularly in metaplastic carcinomas, highlighting potential therapeutic strategies targeting the pathways affected by Ccn6 deficiency.
References:
1. Tran, Mai N, Kleer, Celina G. 2018. Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas. In Journal of cell communication and signaling, 12, 13-19. doi:10.1007/s12079-018-0451-9. https://pubmed.ncbi.nlm.nih.gov/29357008/
2. Leask, Andrew. 2016. CCN6: a modulator of breast cancer progression. In Journal of cell communication and signaling, 10, 163-4. doi:10.1007/s12079-016-0321-2. https://pubmed.ncbi.nlm.nih.gov/27086280/
3. Gonzalez, Maria E, Brophy, Bryce, Eido, Ahmad, Fearon, Eric R, Kleer, Celina G. . CCN6 Suppresses Metaplastic Breast Carcinoma by Antagonizing Wnt/β-Catenin Signaling to Inhibit EZH2-Driven EMT. In Cancer research, 84, 3235-3249. doi:10.1158/0008-5472.CAN-23-4054. https://pubmed.ncbi.nlm.nih.gov/39024552/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.